tresperimus (Fournier Pharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nametresperimus (Fournier Pharma)
Drug Alias Nametresperimus
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsOcular inflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFournier Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFournier Pharma Corp
Active IndicationsN/A
Inactive IndicationsOcular inflammation

Other Information

ATC CodeN/A
Related LinksN/A